SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 50 filers reported holding SQZ BIOTECHNOLOGIES CO in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $254,093 | -51.8% | 941,086 | -0.1% | 0.00% | – |
Q1 2023 | $527,382 | -24.3% | 941,752 | 0.0% | 0.00% | – |
Q4 2022 | $696,896 | -67.5% | 941,752 | +0.0% | 0.00% | – |
Q3 2022 | $2,146,000 | -28.3% | 941,404 | 0.0% | 0.00% | – |
Q2 2022 | $2,994,000 | -39.0% | 941,404 | -7.8% | 0.00% | – |
Q1 2022 | $4,909,000 | -46.2% | 1,020,803 | -0.1% | 0.00% | – |
Q4 2021 | $9,129,000 | -37.7% | 1,022,245 | +0.7% | 0.00% | – |
Q3 2021 | $14,643,000 | +13.8% | 1,015,463 | +14.0% | 0.00% | – |
Q2 2021 | $12,868,000 | +154.5% | 890,577 | +141.0% | 0.00% | – |
Q1 2021 | $5,056,000 | -21.7% | 369,582 | +65.8% | 0.00% | – |
Q4 2020 | $6,460,000 | – | 222,903 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
683 Capital Management, LLC | 1,330,889 | $984,857 | 0.08% |
Artal Group S.A. | 1,606,309 | $1,189 | 0.07% |
Sandy Cove Advisors, LLC | 51,707 | $38,263 | 0.03% |
MAVERICK CAPITAL LTD | 1,068,155 | $790,435 | 0.02% |
AMERICAN INTERNATIONAL GROUP, INC. | 2,517,173 | $1,862,708 | 0.01% |
Temasek Holdings (Private) Ltd | 2,758,169 | $2,041,045 | 0.01% |
RBF Capital, LLC | 127,930 | $94,000 | 0.01% |
ADVISORS MANAGEMENT GROUP INC /ADV | 14,000 | $10 | 0.00% |
Ergoteles LLC | 64,215 | $47,519 | 0.00% |
Baldrige Asset Management LLC | 5,000 | $4 | 0.00% |